Delivra Health CEO: Q1 growth driven by online sales – ICYMI

Delivra Health Brands Inc. reported strong Q1 growth, primarily fueled by significant e-commerce sales increases for its key brands, with Dream Water up 74% and LivRelief up 16%, attributed to strategic online investments. The company also improved its Adjusted EBITDA to $56,000, marking 12 consecutive quarters of positive performance. Management anticipates continued revenue and gross profit gains from a planned early 2026 relaunch of LivRelief infused sales following a transition to a new distribution partner, while maintaining a focus on controlled e-commerce channel investments and sustained profitability.

Analysis

Delivra Health Brands Inc. (DHB) reported a strong first quarter, primarily driven by significant e-commerce sales growth. Dream Water's online sales surged by 74%, while LivRelief saw a 16% increase, attributed to strategic investments in online platforms, including subscriptions and affiliate marketing programs. This e-commerce focus allows for greater control over pricing and promotional activities, which management expects to sustain future growth.

The company demonstrated continued financial discipline, with Adjusted EBITDA improving to $56,000, marking its twelfth consecutive quarter of positive performance. Management highlighted responsible SG&A management alongside reinvestment in marketing and innovation. A key strategic initiative involves the planned early 2026 relaunch of LivRelief infused products, following a transition from Canopy Growth to a new contract manufacturer, which is projected to contribute additional revenue and gross profit in Q3 and Q4.

CEO Gord Davey expressed confidence in the sustainability of this growth, emphasizing the company's proven formula for balancing profitability with investment. The transition for LivRelief infused products, despite a temporary sales drop, is expected to expand market access through provincial networks and medical platforms. This proactive approach to channel management and product innovation underpins an optimistic outlook for continued revenue expansion.

Key Decisions for Investors

• Investors should monitor the continued growth trajectory of e-commerce sales for Dream Water and LivRelief, as this channel is a primary driver of current performance.
• Evaluate the impact of the LivRelief infused product relaunch in early 2026, particularly its contribution to Q3/Q4 revenue and gross profit, as this represents a significant future growth catalyst.
• Assess the company's ability to maintain its positive Adjusted EBITDA trend while continuing strategic investments in marketing and product innovation, indicating sustainable operational efficiency.